Lavender (Lavandula angustifolia Mill.): A Comprehensive Reference
1. Identity and Botanical Description
Taxonomy and Nomenclature
Lavender (Lavandula angustifolia Mill.), also known as English lavender or true lavender, is a perennial sub-shrub plant belonging to the Lamiaceae (mint) family. Lavender oil is the common name for the essential oil of this plant. The genus Lavandula encompasses more than 30 recognized species, and the commonly encountered medicinal species include Lavandula angustifolia (true lavender), Lavandula latifolia (spike lavender), and Lavandula × intermedia (lavandin, a hybrid of the two preceding species).
Natural Source and Habitat
Lavender is native to the Mediterranean region, the Arabian Peninsula, and Russia. The plant is cultivated or gathered to obtain the oil for medicinal use; lavender oil is obtained by passing a current of steam through the flowering tops of the plant. This fragrant and adored species sprouts long, branching stems with clusters of purple flowers, which provide the highest concentration of essential oils.
Commercially Important Species and Their Distinctions
- Lavandula angustifolia (True Lavender / English Lavender): This is the species most celebrated by aromatherapists and researchers and is considered to be highly therapeutic. True lavender is characteristically high in both linalool and linalyl acetate esters while being relatively low in camphor. As it is a somewhat "fussy" plant with a smaller essential oil yield, L. angustifolia oils are more expensive and are also more prone to adulteration.
- Lavandula × intermedia (Lavandin): Also called lavandin, this species is a mass-cultivated hybrid of Lavandula angustifolia and Lavandula latifolia (spike lavender). Lavandin plants produce an essential oil that is more intense, refreshing, and herbaceous and is relatively higher in camphor and 1,8-cineole.
Common Forms and Preparations
Herbal medicines containing lavender oil are usually available in liquid forms to be taken by mouth or as a bath additive. Beyond these pharmaceutical presentations, lavender is used in a wide range of additional forms:
- Essential oil (aromatherapy / inhalation): The most widely studied inhalational form, used in diffusers, direct inhalation, and steam.
- Oral capsules: Silexan is a high-quality fine lavender oil, licensed as an active ingredient in medicines for the relief of mild anxiety disorders, registered as a Herbal Medicinal Product (HMP), Traditional Herbal Medicinal Product (THMP), listed medicine, or natural health product in numerous countries (under brand names such as Kalms Lavender, Lasea®, Laitea®, Laseaxan®, Lavekan®, Seremind®, or Laila), and as a food supplement (under the brand names CalmAid® and Lavela) in the United States.
- Topical applications: Diluted in carrier oils for massage or application to the skin.
- Dried herb / herbal tea infusion: Prepared from dried flowers or leaves.
- Tinctures and liquid extracts: Alcoholic or hydroalcoholic preparations for oral use.
- Bath additives: Lavender oil diluted in bath preparations.
2. Key Chemical Constituents
Volatile Constituents of the Essential Oil
Lavender essential oil is a colorless or pale-yellow liquid containing around 170 volatile organic compounds (VOCs). Monoterpene and its derivatives, including linalool, linalyl acetate, lavandulol, geraniol, bornyl acetate, borneol, terpineol, eucalyptol, and lavandulyl acetate, are the oil's main constituents, which may exceed 90% of total VOCs. It also contains a small fraction of sesquiterpenes and their derivatives, triterpenoids, and other phenolic compounds that give the oil a complex flavor.
Standard lavender oil should include 20–45% linalool and 25–47% linalyl acetate, but less than 1.5% camphor. The prevalent lavender varieties are rich in linalool and linalyl acetate, which are the most frequent monoterpenes they contain. The composition of essential oils is primarily influenced by the genetic makeup of the plant, while environmental and propagation factors can also exert a considerable influence.
Other Constituents of the Whole Plant
The major constituents of lavender, including volatile oils such as linalool, limonene, perillyl alcohol, linalyl acetate, terpene, coumarin, tannin, caffeic acid, and camphor, vary in relative concentrations among different species. Lavender has over 100 constituents including tannins, 0.5–1.5% volatile oil, coumarins, flavonoids, and ursolic acid.
Principal Bioactive Compounds
- Linalool: The dominant monoterpene alcohol and primary aromatic constituent of L. angustifolia essential oil. It is implicated in the majority of the plant's neurological and antimicrobial effects (see Mechanisms of Action below).
- Linalyl acetate: The major ester of lavender oil. N-methyl-D-aspartate (NMDA) receptors are antagonized by linalyl acetate by blocking calcium channels and thus enhancing gamma-aminobutyric acid (GABA) action to counterbalance stimulatory glutamate.
- Camphor and 1,8-Cineole: Present in low amounts in true lavender but higher in lavandin. These compounds contribute a more medicinal or sharp aromatic note and are associated with stimulant, rather than sedative, characteristics.
- Terpinen-4-ol, α-terpineol, borneol, lavandulol, lavandulyl acetate: Minor but analytically significant constituents contributing to the antimicrobial profile of the oil.
- Coumarins, tannins, rosmarinic acid, and flavonoids: Non-volatile polyphenolic constituents present in the whole herb and aqueous extracts, contributing antioxidant and anti-inflammatory effects.
3. Traditional and Historical Use
Etymology and Origins
In ancient Rome, lavender was used to scent bathwater; the name lavender comes from the Latin verb lavare, which means "to wash." Lavender boasts a remarkably long and diverse history of medicinal use, dating back thousands of years to ancient civilizations.
Ancient Egypt
In ancient Egypt, lavender was used in cosmetics and as an antiseptic when embalming. It was used by royal families and high priests. Traces of lavender were even found in the tomb of the Egyptian pharaoh Tutankhamun.
Ancient Greece
In ancient Greece, the lavender plant was referred to as Nardus (named after the Syrian city of Narada). The Greek physician Theophrastus, in his work "Concerning Odors," wrote about lavender. Ancient Greek physicians like Dioscorides (1st century AD) documented lavender's use internally for indigestion, headaches, and sore throats, and externally for cleaning wounds, burns, and treating skin ailments. Lavender was a favorite ingredient in herbal baths of both Greeks and Romans.
Ancient Rome
This is perhaps one of the most well-documented ancient uses. Roman soldiers carried lavender with them to dress and clean war wounds, recognizing its purifying and healing properties. The Romans also used it widely in their baths for cleansing and soothing. A Greek physician living in Rome documented lavender in his book "De Materia Medica." It noted that when taken internally, lavender relieves indigestion, headaches, and sore throats. When applied externally, lavender cleanses wounds, burns, and treats skin ailments.
Arab and Islamic Medicine
The De Materia Medica served as the foundation for Arab physicians who read Syrian and Old Persian translations. The Arabs dominated the Mediterranean culture around the seventh century AD, and brought their medicine to Spain, from where it spread to the rest of Europe. Their greatest known physician, Abu Ali Sina, known as Avicenna (980 AD – 1037 AD), mentioned the healing uses of lavender.
Medieval Europe
Due to its insecticidal properties, lavender was strewn over floors in castles and sickrooms as a disinfectant and deodorant. It was used as an ingredient in smelling salts and was used to disinfect wounds during wartime. It was used as an insecticide to protect linens from moths. During the Middle Ages it was also considered an herb of love and was used as an aphrodisiac. It was believed to ward off the plague, possibly due to its insect-repelling properties (fleas were carriers) and its use in purifying sickrooms. "Four Thieves Vinegar," a popular protective blend during the plague, often contained lavender.
Herbalists of this period noted its calming effect on the nervous system, recommending it for "griefs and pains of the head and brain." Charles VI of France reportedly slept with lavender in his pillow for better sleep.
Summary of Traditional Preparations
- Floral baths and bathwater scenting (Greece, Rome)
- Topical poultices and wound dressings (Rome, medieval Europe)
- Internal decoctions and syrups for digestive complaints and headaches (Greece, Arab medicine)
- Room fumigation and strewing (medieval Europe)
- Aromatic pillows and sachets for sleep promotion (medieval Europe)
- Smelling salts (18th–19th century Europe)
4. Mechanisms of Action
GABAergic Pathways
The principal component of lavender is the acyclic monoterpene linalool, which has been shown to have GABAA receptors as main targets. Volatile components are reported to bind to odorant receptors at the olfactory epithelium. Linalool vapor significantly potentiated GABAergic currents and modulated GABAA receptors in human embryonic kidney cells (HEK293 cells) and Xenopus oocytes. Harada et al. (2018) confirmed that linalool's effect was mediated by GABA, since it was antagonized by flumazenil. Because the GABAergic circuit has been found to actively modulate arousal in the locus coeruleus, it is possible to assume that lavender essential oil might induce arousal decrease acting through the GABAergic pathway.
Serotonergic Pathways
Lavender and linalool were also able to bind the serotonin transporter (SERT). LEO significantly displaced ³H-citalopram from binding to the SERT in a dose-dependent manner, which means that LEO might have an antidepressant-like effect via this specific transporter. This effect was also detected for linalool, one of the main constituents of lavender essential oil, but not for linalyl acetate. Serotonin transporters are inhibited to spare more serotonin to stabilize mood and behavior.
Voltage-Operated Calcium Channels (VOCCs)
Silexan (the oral lavender preparation) causes a potent inhibition of voltage-dependent calcium channels (VOCCs) in synaptosomes, primary hippocampal neurons, and stably overexpressing cell lines, which have been shown to play an important role in both anxiety and depression. Inhibition of VOCCs can lead to an attenuation of the overreaching, situationally inadequate stress response of the central nervous system associated with anxiety and mood disorders. Additionally, Silexan significantly reduces the 5-HT1A binding potential in brain clusters encompassing the temporal gyrus, the fusiform gyrus, the hippocampus, the insula, and the anterior cingulate cortex, which may lead to an increase of extracellular serotonin levels.
NMDA Receptor Antagonism
The results of in vitro pharmacological studies showed that lavender essential oil and its main components exert affinity for the glutamate NMDA-receptor in a dose-dependent manner with an IC50 value of 0.04 μl/mL for lavender oil. According to this data, the anxiolytic and antidepressant-like effects attributed to lavender may be due to an antagonism on the NMDA-receptor and inhibition of SERT.
Cholinergic and Neuroprotective Effects
The essential oil from lavender helps to reduce the degradation of acetylcholine while simultaneously increasing the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione by inhibiting acetylcholinesterase (AChE). It has the potential to reduce oxidative stress and prevent memory loss. These effects have been demonstrated in animal and in vitro models, and the clinical relevance in humans remains to be fully established.
Antimicrobial Activity
At a concentration of 0.6 or 1.0 μl/mL, lavender essential oil has a high inhibitory property against the growth of gram-positive bacteria (Bacillus subtilis, S. aureus) and gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa). The essential oil has been reported to be active against yeasts and molds like Candida sp., A. niger, and P. expansum, with MICs 2.5–3 times lower than for bacteria. These are primarily in vitro findings; evidence of meaningful clinical antimicrobial efficacy in humans is limited.
5. Scientific Evidence by Area of Use
5.1 Anxiety and Anxiety Disorders
International organizations, such as the World Health Organization (WHO), the European Scientific Cooperative on Phytotherapy (ESCOP), and the European Medicines Agency (EMA) approve this medicinal plant to relieve stress, restlessness, and anxiety. The strongest body of clinical evidence for any single lavender preparation exists for Silexan, the standardized oral lavender oil capsule.
Silexan is an active substance derived from lavender oil; six studies investigated its efficacy in patients with subthreshold and generalized anxiety disorders as well as in mixed anxiety and depressive disorder (MADD). Silexan taken orally at a daily dose of 80 mg for 10 weeks was significantly superior to placebo in reducing psychic and somatic symptoms of anxiety and was as effective as 0.5 mg/day lorazepam and 20 mg/day paroxetine.
A 2017 meta-analysis of five studies involving 1,165 participants with anxiety diagnoses found Silexan (lavender oil) to be significantly superior to placebo in ameliorating anxiety symptoms independently of diagnosis. The study also found a tendency for greater clinical effect when analyzing separately generalized anxiety disorder patients in comparison with all other diagnoses.
To investigate the anxiolytic effect of Silexan in patients with subthreshold anxiety, a meta-analysis that included all published trials with Silexan in this indication was performed. Three randomized, placebo-controlled trials in subthreshold anxiety disorders (anxiety disorder not otherwise specified, restlessness and agitation, mixed anxiety and depressive disorder) were included. Eligible participants with a baseline Hamilton Anxiety Rating Scale (HAMA) total score ≥ 18 points received 1 × 80 mg/day Silexan or placebo for 10 weeks.
A 2019 independent meta-analysis of data from five randomized controlled trials involving 1,320 participants with anxiety disorders found that Silexan 160 mg outperformed paroxetine and lorazepam in reducing anxiety symptoms. Silexan is also well-tolerated; the only adverse effects that have been identified so far are mild gastrointestinal symptoms and these are uncommon.
In one double-blind, randomized study, Silexan and lorazepam were given for 6 weeks to 78 adult male and female subjects diagnosed with generalized anxiety disorder (GAD). Anxiety levels at baseline and week 6 were rated using the Hamilton Anxiety Rating Scale, with the results suggesting that Silexan effectively decreases symptoms of GAD comparably to the benzodiazepine lorazepam. A high degree of safety was also demonstrated with Silexan. Anxiety decreased by 45% in the Silexan group and 46% in the lorazepam group.
Limitations: All trials available for analysis of Silexan were initiated by the manufacturer of Silexan and performed in one country (Germany). Generalizability to other populations and lavender preparations is uncertain.
5.2 Depression and Mood
In patients with mild or moderate major depression, Silexan was superior to placebo and comparably effective to 50 mg/day sertraline. This finding derives from a small number of manufacturer-sponsored trials. Evidence for lavender in depression independent of the Silexan research program is limited, and broader replication is needed before definitive conclusions can be drawn.
5.3 Sleep and Insomnia
Lavender is called "the broom of the brain" in different oriental traditional medicines. It is one of the most used plants for patients with sleep disorders. Research has reviewed its use for sleep disorders in patients with different diseases, from cancers and end-stage renal disease to neurological-psychiatric diseases (e.g., depression, dementia, and autism), respiratory, cardiac, and metabolic diseases.
A 2026 meta-analysis indicated that the sleep-enhancing effect of lavender essential oil intervention in adults was significant (standardized mean difference = −0.56, 95% CI [−0.96, −0.17], P = .005). This systematic review examined the sleep-enhancing effect of lavender essential oil in adults through a search of RCTs in PubMed, Embase, Cochrane Library, CINAHL, and Web of Science. Eleven RCTs, encompassing a total of 628 adult participants, were incorporated into this analysis.
Lavender essential oil was the most frequently studied essential oil for sleep, with results trending toward a positive effect. A small to moderate benefit of lavender on sleep was found in a systematic review of the literature specific to lavender and sleep.
Limitations: Many sleep studies involve small sample sizes, heterogeneous populations, short durations, and lack of blinding for inhaled preparations (since the smell of lavender is immediately perceptible to participants). Subjective outcome measures (self-reported sleep quality questionnaires) predominate, and placebo-controlled blinding is methodologically difficult for aromatherapy trials.
5.4 Pain
A systematic review that searched major databases found six trials involving 415 participants, concluding that the use of lavender could significantly reduce pain in women with episiotomy. Some in vitro studies also showed that lavender has carminative (smooth muscle relaxing), anti-flatulent, and anti-colic properties.
Evidence also exists from clinical trials for lavender aromatherapy in labor pain, postoperative pain, and dysmenorrhea, though individual trials are small and methodological quality is variable. Most pain research on lavender is preliminary.
5.5 Antimicrobial and Wound Healing
In the last two decades, studies have been carried out on the antimicrobial effectiveness of lavender essential oils (LEO), with the result that there are potential applications for LEO as an antiseptic, as a combination partner in disinfectants, for preservation, impregnation, and possibly also for decontamination of indoor air. Even more promising is the use of LEO in combination with antibiotics and antiseptics in order to synergistically enhance their effectiveness.
Findings indicate that lavender, largely through its major constituents linalool and linalyl acetate, exhibits antioxidant, antimicrobial, and anti-inflammatory properties that support granulation, re-epithelialization, and collagen remodeling. However, despite the fact that lavender oil was considered particularly beneficial during World War I, there is little evidence that it helps to accelerate wound healing and reduces scarring in humans, and most mechanistic data come from in vitro and animal studies.
5.6 Cognitive Function and Dementia
The essential oil from lavender helps to reduce the degradation of acetylcholine while simultaneously increasing the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione by inhibiting acetylcholinesterase (AChE). It has the potential to reduce oxidative stress and prevent memory loss. These data suggest that lavender has anticholinergic, neuroprotective, and antioxidant properties that may help treat Alzheimer's disease. These findings are largely preclinical; robust clinical trials in dementia populations are lacking.
5.7 Other Areas of Emerging or Preliminary Interest
- Antifungal: In vitro evidence shows activity against Candida albicans and various molds, but clinical use is unproven.
- Antioxidant: Lavandula species exhibit potential for diverse biological applications, particularly owing to their antioxidant activity. Human clinical evidence in this area is limited.
- Post-COVID-19 symptoms: Data indicate that silexan may influence sleep quality as well as anxiety or depressive disorders in individuals with post-COVID-19. This is a very early area of investigation.
6. Body Systems and Health Areas Associated with Lavender
- Central Nervous System: Anxiety, stress, sleep disorders, mood disorders (depression), cognitive function
- Integumentary System: Wound healing, antimicrobial skin applications, eczema, dermatitis
- Gastrointestinal System: Carminative, antiflatulent, anti-colic (traditional use; limited clinical evidence)
- Musculoskeletal System: Analgesic applications, including post-episiotomy and postoperative pain
- Immune/Antimicrobial: Antifungal and antibacterial properties (primarily in vitro)
- Endocrine System: Investigated in relation to potential endocrine-disrupting effects (see Safety section)
7. Dosage Forms and Reported Dosages
Oral (Standardized Oil Capsules — Silexan)
Eligible participants in clinical trials received 1 × 80 mg/day Silexan or placebo for 10 weeks. In the generalized anxiety disorder comparison trial, the product was available in immediate-release soft gelatin capsules containing 80 or 160 mg of lavender oil. In one clinical study, 80 mg of Lavandula angustifolia essential oil taken orally in capsule form was safely used for up to 10 weeks. Lavandula essential oil is typically taken orally at doses of 80–180 mg per day.
Oral (Liquid/Tincture — Traditional/EMA Monograph)
The EMA Community Herbal Monograph specifies a daily dose of 20–80 mg (1–4 drops) for oral liquid preparations.
Whole Herb (Dried Flower/Leaf)
Whole dried Lavandula herb (leaf and flower) can be taken in divided doses, up to 800 mg per day.
Inhalation / Aromatherapy
As aromatherapy, 1–3 drops are inhaled at a time as needed.
Topical / Pharmaceutical Form (EMA)
The EMA monograph specifies the herbal preparation as essential oil obtained by steam distillation from the flowering tops of Lavandula angustifolia Miller, in liquid dosage form for oral use and as a bath additive.
8. Safety Considerations and Interactions
General Tolerability
In generalized anxiety disorder trials, Silexan is more efficacious than placebo. Adverse event rates for Silexan were comparable to placebo and lower than for the active control paroxetine. Silexan is well-tolerated; the only adverse effects that have been identified so far are mild gastrointestinal symptoms and these are uncommon.
Adverse Effects from Oral Use
When lavender teas and extracts are taken by mouth, they may cause headache, changes in appetite, and constipation. Lavender oil can be toxic if ingested in large amounts. Symptoms of poisoning may include nausea, vomiting, diarrhea, difficulty breathing, and confusion. Ingestion of approximately 5 mL of diluted essential oil can cause toxicity in adults; for children, as little as 2–3 mL.
Skin and Topical Use
As with other essential oils, the use of lavender raises concerns about possible allergic reactions and skin irritation. Cavanagh and Wilkinson claim that L. latifolia and L. angustifolia do not cause skin sensitization and are relatively moderately irritating to the skin, and that L. angustifolia does not cause phototoxicity in well-cited essential oil safety studies.
Drug Interactions
There are theoretical reasons to suspect that lavender might interact with some sedative drugs or herbs, which is especially important if a patient has an upcoming surgical procedure. Using lavender supplements with sedative medications may increase drowsiness. Sources also caution against using lavender together with other herbal or health supplements that can lower blood pressure.
Pregnancy and Lactation
Little is known about whether it's safe to use lavender during pregnancy or while breastfeeding.
Potential Endocrine Activity (Contested)
A notable safety signal that has generated scientific debate concerns the potential endocrine-disrupting properties of lavender oil and its constituents. Previous clinical cases established a link between hygiene-product use of lavender oil and tea tree oil and prepubertal gynecomastia in boys. In vitro studies confirmed that lavender oil and tea tree oil possess weak estrogenic and antiandrogenic activities that may contribute to an imbalance in estrogen and androgen pathway signaling. Three prepubertal girls and one boy with clinical evidence of estrogenic action and a history of continuous exposure to lavender-containing fragrances were studied. Breast growth dissipated in all patients with discontinuation of the fragranced products.
However, this finding is contested. A subsequent guideline-compliant in vitro study found no relevant anti-estrogenic or androgen receptor (AR)-mediated activity in recombinant yeast cell-based screening tests and guideline reporter gene in vitro assays in mammalian cells. Concerning the reported cases of prepubertal gynecomastia and/or premature thelarche, the lines of evidence for estrogen- or androgen-related endocrine activity, the resulting adversity, and the biologically plausible link between those two cannot be established for the lavender components linalool and linalyl acetate. Furthermore, the presence of other molecules or contaminants that could contribute to premature thelarche and prepubertal gynecomastia should be investigated, especially since the in vitro study methodology is questionable. A very high amount of the individual oil's components — a million times higher than estradiol levels — is necessary to obtain a weak activity compared with whole essential oils, and compound bioavailability was not taken into account.
In summary, an association between topical lavender product use and prepubertal breast development has been reported in case studies, and cessation of product use correlated with resolution of symptoms. The mechanistic evidence is disputed, and causal determination has not been established. This remains an area of ongoing scientific scrutiny.
Regulatory Status (Selected)
For lavender, several monographs exist. The EMA has published monographs on lavender essential oil, detailing its traditional uses for conditions such as anxiety and sleep disturbances. The U.S. National Center for Complementary and Integrative Health (NCCIH) provides information on the safety and efficacy of lavender, highlighting its uses in aromatherapy and potential side effects. Lavandula has Generally Recognized as Safe (GRAS) status in the USA, meaning there is a consensus of expert opinion regarding the safety of its use.
References
Go back